Cyclooxygenase 2Cyclooxygenase 1Cyclooxygenase InhibitorsCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesInflammationInflammation MediatorsBiological MarkersColitis, UlcerativeBlood SedimentationDinoprostoneIndomethacinNeopterinArthritis, RheumatoidC-Reactive ProteinAnti-Inflammatory AgentsProstaglandinsCrohn DiseaseWhole Body ImagingSarcoidosisCalgranulin BIsoenzymesSeverity of Illness IndexTumor Necrosis Factor-alphaArachidonic AcidLiver CirrhosisCytokinesMacrophagesSynovitisSynovial FluidNitrobenzenesInterleukin-6ArthritisTime FactorsAnti-Inflammatory Agents, Non-SteroidalArthritis, JuvenileEnzyme-Linked Immunosorbent AssayLipoxygenase InhibitorsCase-Control StudiesRadiopharmaceuticalsBiopsyIbuprofenNeutrophilsSulfonamidesMultimodal ImagingProspective StudiesPyrazolesFluorodeoxyglucose F18Hepatitis C, ChronicThromboxane B2RNA, MessengerPositron-Emission TomographyAtherosclerosisCells, CulturedDisease Models, AnimalLipopolysaccharidesInterleukin-8Endothelium, VascularArachidonic AcidsInflammatory Bowel DiseasesDisease ProgressionIntestinal MucosaImmunohistochemistryReverse Transcriptase Polymerase Chain ReactionMembrane ProteinsFlurbiprofenMagnetic Resonance ImagingLipoxygenase6-Ketoprostaglandin F1 alphaEicosanoidsSensitivity and SpecificityTomography, X-Ray ComputedEpoprostenolMasoprocolAspirinLeukocytesChronic DiseaseImmunoglobulin GLiverTreatment OutcomeMice, Inbred C57BLAntirheumatic AgentsMultiple SclerosisPredictive Value of TestsAnalysis of VarianceInterleukin-10Reproducibility of ResultsPiroxicamRisk FactorsThromboxane A2DiclofenacIntramolecular OxidoreductasesReceptors, Prostaglandin EFollow-Up StudiesThromboxane-A SynthaseNaproxenGene Expression RegulationArachidonate 5-LipoxygenaseThromboxanesMeclofenamic Acid